Administrative Core
行政核心
基本信息
- 批准号:10668955
- 负责人:
- 金额:$ 20.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-22 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdministratorAdvocacyAdvocateBasic ScienceClinical ResearchCollaborationsCommunicationConsultationsDevelopmentDiseaseDisputesEnsureEvaluationFoundationsFox Chase Cancer CenterFund RaisingFundingGenerationsGrantHead and Neck CancerHead and neck structureHuman ResourcesHuman Subject ResearchInstitutionLaboratory FindingLeadershipMalignant neoplasm of lungMentorsModelingMonitorNational Cancer InstituteNorth CarolinaOccupational activity of managing financesPathway interactionsPatientsPreparationPrincipal InvestigatorPrivatizationProgram DevelopmentProgram EvaluationProgress ReportsPublicationsRegulationReproduction sporesResearchResearch PersonnelResearch PriorityResearch Project GrantsResourcesScienceSeriesSiteSourceTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesWorkYale Cancer Centeranticancer researchcareer developmentcost effectivemedical schoolsmeetingsneoplasm resourcenoveloperationoutreachprogramssuccesstherapy resistanttimelinetranslational applicationstranslational goaltranslational scientisttranslational studywebsite development
项目摘要
SUMMARY
The Administrative Core (Core A) will be directed by Dr. Barbara Burtness, Principal Investigator of the Yale
Head and Neck SPORE in Lung Cancer (YHN-SPORE), and co-directed by Dr. Edward Kaftan with support from
the program financial management team and Michele Dingus, Associate Administrator. Drs. Erica Golemis and
Wendell Yarbrough will serve as Site Leaders for Fox Chase Cancer Center and University of North Carolina,
respectively. Careful oversight by the Administrative Core will be critical to ensure the success of the YHN-
SPORE. The Administrative Core will serve as the central coordination point for all YHN-SPORE investigators,
with responsibility for strategic and scientific direction, and monitoring progress of all projects and cores towards
the translational goals of the SPORE. The Core Director and Co-Directors will have responsibility for leading the
SPORE, setting translational research priorities, identifying new translational research opportunities, monitoring
the progress of all projects, cores and developmental projects and determining changes in direction of projects,
cores and translational research as needed. Interactions among YHN-SPORE investigators will be facilitated by
Core A to accelerate the translation of laboratory findings to the bedside through rational and rigorous
translational and clinical studies. If required, the Core A Director will manage conflicts among SPORE
investigators. As a team, the Core personnel will provide financial oversight, maintain communication among
project and core leaders and coordinate bi-weekly meetings, quarterly meetings of the Executive Committee,
annual meetings of the Internal/External Advisory boards and an annual YSHN-SPORE retreat. In addition to
these functions, the Core will be the primary interface with the NCI, Fox Chase Cancer Center, University of
North Carolina, head and neck or other disease- or pathway-focused SPOREs, Yale Cancer Center and Yale
School of Medicine, and will coordinate outreach efforts, including publications (internal and external), website
development, seminars, and patient/research advocacy activities. Through these administrative activities, Core
A will be essential to the organization of the YHN-SPORE program, to advancing science to overcome treatment
resistance in head and neck cancer, developing models and approaches to advance the field, and mentoring a
new generation of head and neck cancer translational researchers.
概括
行政核心(核心 A)将由耶鲁大学首席研究员 Barbara Burtness 博士指导
肺癌头颈 SPORE (YHN-SPORE),由 Edward Kaftan 博士联合指导,并得到以下机构的支持
项目财务管理团队和副管理员 Michele Dingus。博士。艾丽卡·戈勒米斯和
Wendell Yarbrough 将担任福克斯蔡斯癌症中心和北卡罗来纳大学的现场领导,
分别。行政核心的认真监督对于确保 YHN 的成功至关重要
孢子。行政核心将作为所有 YHN-SPORE 调查员的中央协调点,
负责战略和科学方向,并监测所有项目和核心的进展,以实现
SPORE 的转化目标。核心董事和联合董事将负责领导
SPORE,设定转化研究优先事项,确定新的转化研究机会,监测
所有项目、核心和开发项目的进展并确定项目方向的变化,
根据需要进行核心和转化研究。 YHN-SPORE 调查员之间的互动将通过
核心A通过理性严谨加速实验室发现转化为临床
转化和临床研究。如果需要,核心 A 主管将管理 SPORE 之间的冲突
调查人员。作为一个团队,核心人员将提供财务监督,保持内部沟通
项目和核心领导人并协调执行委员会的双周会议、季度会议,
内部/外部咨询委员会年度会议和年度 YSHN-SPORE 务虚会。此外
这些功能,Core 将成为与 NCI、福克斯蔡斯癌症中心、大学的主要接口
北卡罗来纳州,头颈或其他疾病或途径重点孢子,耶鲁癌症中心和耶鲁
医学院,并将协调外展工作,包括出版物(内部和外部)、网站
开发、研讨会和患者/研究宣传活动。通过这些行政活动,核心
对于组织 YHN-SPORE 计划、推进科学克服治疗问题至关重要
头颈癌的抵抗力,开发模型和方法来推进该领域,并指导
新一代头颈癌转化研究人员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA BURTNESS其他文献
BARBARA BURTNESS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA BURTNESS', 18)}}的其他基金
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer
项目 2:HPV 阴性头颈癌的合成致死疗法
- 批准号:
10913240 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
耶鲁头颈癌孢子:克服头颈癌的治疗耐药性
- 批准号:
10267672 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer
项目 2:HPV 阴性头颈癌的合成致死疗法
- 批准号:
10267848 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
耶鲁头颈癌孢子:克服头颈癌的治疗耐药性
- 批准号:
10441504 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer
HPV 阴性头颈癌的综合致死疗法
- 批准号:
10838999 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer
项目 2:HPV 阴性头颈癌的合成致死疗法
- 批准号:
10668986 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
耶鲁头颈癌孢子:克服头颈癌的治疗耐药性
- 批准号:
10666936 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
Project 2: Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer
项目 2:HPV 阴性头颈癌的合成致死疗法
- 批准号:
10441510 - 财政年份:2020
- 资助金额:
$ 20.27万 - 项目类别:
相似海外基金
Screening, Tracking and Treatment for Anxiety and Depression in Community Colleges
社区大学焦虑症和抑郁症的筛查、跟踪和治疗
- 批准号:
10615195 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别:
UAB Blazer BRAIN (Broadening Representation And Inclusion in Neuroscience) Summer Program
UAB Blazer BRAIN(扩大神经科学的代表性和包容性)暑期项目
- 批准号:
10595055 - 财政年份:2022
- 资助金额:
$ 20.27万 - 项目类别:
Leveraging the national infrastructure of trusted organizations to increase representation of Latinos in dementia research
利用受信任组织的国家基础设施来增加拉丁裔在痴呆症研究中的代表性
- 批准号:
10606520 - 财政年份:2021
- 资助金额:
$ 20.27万 - 项目类别: